Table 3.
Quantitative determination of RDV and APX in pharmaceutical preparations using the proposed methods, as well as the results of using the standard addition technique, with statistical comparison to the reported methods.
| Recovery ± RSD | |||||
|---|---|---|---|---|---|
| RDV | Reported method | APX | Reported method [28] | ||
| Remdesivir- vial a | 99.64 ± 0.888 | 99.82 ± 0.962 | Eliquis tablets a | 100.05 ± 0.769 | 100.11 ± 1.064 |
| Standard addition b | 101.12 ± 1.480 | Standard addition b | 100.52 ± 0.987 | ||
| t-test (2.306)c | 0.317 | t-test (2.306)c | 0.101 | ||
| F-test (6.388)c | 0.849 | F-test (6.388)c | 0.522 | ||
a
Average of five determinations.
b
Average of three determinations.
c
The values in parentheses are tabulated values of t and F at P = 0.05.